Category:Drug safety

A

• Abandoned drugs‎ (831 P)
• Adulteration‎ (2 C, 59 P)
• Adverse effects of psychoactive drugs‎ (1 C, 13 P)

D

• Drug-induced diseases‎ (1 C, 18 P)

N

• National agencies for drug regulation‎ (2 C, 46 P)

P

• Pharmacovigilance databases‎ (6 P)

V

• Vaccine controversies‎ (2 C, 24 P)

W

• Withdrawn drugs‎ (1 C, 217 P)

• Drug recall
• Drug safety
• Hazardous drugs
• Pharmacovigilance

0–9

• 1901 diphtheria antitoxin contamination incident

A

• Adverse drug reaction
• Adverse effect

B

• Baxter Althane disaster
• Biodyl
• Biologics Control Act
• Biologics license application

C

• Center for Veterinary Medicine
• Chicago Tylenol murders
• 2008 Chinese heparin adulteration
• Common Technical Document
• Cutter Laboratories

D

• Drug allergy
• Drug checking
• Drug expiration
• Drug Safety
• Drug Safety Research Unit
• Drugs Controller General of India

E

• Electronic common technical document
• Elixir sulfanilamide
• Eosinophilia–myalgia syndrome
• Aubri Esters
• Ethics committee
• EudraVigilance
• Expiration date

F

• Jonathan Fishbein
• Formularium Slovenicum

G

• David Graham (epidemiologist)

H

• Health Products and Food Branch

I

• Bill Inman
• Insite
• Institute for Safe Medication Practices
• Institutional review board
• International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
• International Overdose Awareness Day
• Investigational New Drug
• Irwin screen

L

• Joel Lexchin
• Lyodura

M

• Marketing Authorisation Application
• Matrixx Initiatives, Inc. v. Siracusano
• List of medicine contamination incidents
• Mefloquine

N

• Naranjo algorithm
• National Research Ethics Service
• National Vaccine Injury Compensation Program
• Needle and syringe programmes
• New Animal Drug Application
• New Drug Application
• New England Compounding Center meningitis outbreak
• NyQuil chicken

O

• Over-the-counter drug

P

• Pharmacovigilance Programme of India
• Poison Prevention Packaging Act of 1970
• Poly Implant Prothèse
• Primodos
• Project Weber/RENEW
• Psychotoxicity

Q

• Qualified Person Responsible For Pharmacovigilance

R

• Reactogenicity
• Reagent testing
• Regulated Product Submissions
• Regulation of therapeutic goods
• Peter Rheinstein
• Risk Evaluation and Mitigation Strategies

S

• Supervised injection site
• Serious adverse event
• Shelf life
• Sindell v. Abbott Laboratories
• Society of Pharmacovigilance, India
• Steroid-induced skin atrophy

T

• Thalidomide
• Thalidomide scandal
• Time temperature indicator
• Topical steroid withdrawal
• Toxic cough syrup
• Trans-European Drug Information

U

• USP Controlled Room Temperature

V

• Vaccine adverse event
• Vaccine Adverse Event Reporting System
• Vaccine Information Statement
• National Childhood Vaccine Injury Act
• Vaccine Safety Datalink
• Vancouver Area Network of Drug Users

Y

• Yellow Card Scheme